HomeAI · summaries
Storia in 2 fonti
Symptoms improved within first week: FDA approves new ADHD drug for children, adults
Simtriyo, the first approved ADHD drug to inhibit norepinephrine, dopamine and serotonin reuptake, improved symptoms within a week; US launch depends on controlled-substance classification, and it is not yet available in Israel
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
medicalxpress.com
FDA approves Simtriyo for treating ADHD in children and adults
The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children 6 years and…
- ·
ynetnews.com
Symptoms improved within first week: FDA approves new ADHD drug for children, adults
Simtriyo, the first approved ADHD drug to inhibit norepinephrine, dopamine and serotonin reuptake, improved symptoms within a week; US launch depends on controlled-substance…